Schizophrenia and the cannabinoid receptor type 1 (CB1): Association study using a single-base polymorphism in coding exon 1

Abuse of cannabis is frequent among the young and is suspected to precipitate schizophrenia in vulnerable subjects. Cannabinoid receptor (CB1) is particularly concentrated in dopamine‐modulated areas of the nervous system. An association between an AAT polymorphism of the CB1 gene and intravenous dr...

Full description

Saved in:
Bibliographic Details
Published in:American journal of medical genetics 2001-12, Vol.105 (8), p.749-752
Main Authors: Leroy, S., Griffon, N., Bourdel, M.C., Olié, J.P., Poirier, M.F., Krebs, M.O.
Format: Article
Language:English
Subjects:
Adult
Adult and adolescent clinical studies
Alleles
Biological and medical sciences
cannabis
DNA - genetics
drug abuse
Exons - genetics
Female
gene
Gene Frequency
Genotype
Humans
Male
Medical sciences
Polymorphism, Single Nucleotide
Psychology. Psychoanalysis. Psychiatry
Psychopathology. Psychiatry
Psychoses
Receptors, Cannabinoid
Receptors, Drug - genetics
Schizophrenia
Schizophrenia - genetics
Schizophrenia - pathology
vulnerability
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abuse of cannabis is frequent among the young and is suspected to precipitate schizophrenia in vulnerable subjects. Cannabinoid receptor (CB1) is particularly concentrated in dopamine‐modulated areas of the nervous system. An association between an AAT polymorphism of the CB1 gene and intravenous drug abuse has been previously reported, but not with schizophrenia. In a French Caucasian population, we compared the distribution of a single‐base polymorphism revealed by MspI within the first exon of the CB1 gene in patients with schizophrenia (n = 102) and ethnic‐ and gender‐matched controls (n = 63). No significant difference was seen in the allele or genotype distribution between the whole sample of schizophrenic patients and controls. However, we found a borderline lack of allele g and a significant lack of gg genotype in the non–substance‐abusing patients compared to substance‐abusing patients, the latter being similar to the controls. These results are the first report of an significant association between CB1 receptor and a subtype of schizophrenia. Studies are needed to confirm and further explore the precise role of the cannabinoid system in schizophrenia. © 2001 Wiley‐Liss, Inc.
ISSN:0148-7299
1096-8628
DOI:10.1002/ajmg.10038